BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Deals

  Vitrisa Therapeutics Acquires Rights to MAKO Clinical Trial Data in wAMD

  Vitrisa Therapeutics, Inc., today announced that it has entered into an option agreement with Ohr Pharmaceutical for certain rights to the data from the MAKO study

  May 16, 2018

   · 

  2 min read
• Drug Development

  CIMZIA® (certolizumab pegol) is the First Therapy to Demonstrate Positive Results in a 52-week, Placebo Controlled Non-Radiographic Axial Spondyloarthritis Study

  UCB today announced positive topline results from C-AXSPAND, a Phase 3 placebo controlled study to investigate the efficacy of CIMZIA® (certolizumab pegol) on the signs and symptoms of active axSpA in patients without x-ray evidence of ankylosing spondylitis (AS).

  May 16, 2018

   · 

  21 min read
• FDA

  FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults

  The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride).

  May 16, 2018

   · 

  6 min read
• Biotech Beach

  NeuroVasc Technologies, Inc. closes Series B financing of $6.3MM

  NeuroVasc Technologies, Inc., announced today that it has closed a $6.3MM Series B Preferred Stock financing.

  May 16, 2018

   · 

  1 min read
• Business

  Genomic Vision Enters Into a Strategic Research Collaboration With Children’s Medical Research Institute (CMRI) on Telomere Length Assay

  Genomic Vision announces the signing of a strategic scientific partnership with Children’s Medical Research Institute (CMRI).

  May 16, 2018

   · 

  4 min read
• Business

  Emulate, Inc. and AstraZeneca Form Strategic Agreement to Work Side-by-Side on Organs-on-Chips Technology to Improve Prediction of Human Safety and Efficacy of Drug Candidates

  AstraZeneca is the first pharmaceutical company to work with Emulate to develop and embed its Organ-on-Chips technology in its laboratories.

  May 16, 2018

   · 

  4 min read
• FDA

  Eagle Pharmaceuticals, Inc. Granted Final FDA Approval for Bendamustine Hydrochloride Ready-to-Dilute Solution in a 500ml Admixture

  Eagle to ship 500ml admixture product immediately

  May 16, 2018

   · 

  3 min read
• Policy

  BioLineRx Announces Grant of European Patent Covering Use of BL-8040 with Cytarabine for Treating Acute Myeloid Leukemia

  Patent valid through March 2034, with up to five years’ patent term extension

  May 16, 2018

   · 

  4 min read
• Business

  Roivant Expands Senior Leadership with Key Hires

  Dr. Sam Azoulay as Chief Medical Officer and Adele Gulfo as Chief of Commercial Development

  May 16, 2018

   · 

  3 min read
• Genetown

  EIP Pharma Secures $20.5 Million in Series B Financing

  Proceeds to Support Continued Development of Neflamapimod for Alzheimer’s Disease

  May 16, 2018

   · 

  3 min read